Case Studies
A global multi-billion-dollar specialty pharmaceutical company was acquiring a smaller company with a pipeline of pain and spasticity drugs that would complement its own R&D…
Case Studies
When it comes to launching a new product, even companies with the most meticulously planned schedules can find themselves missing milestones while waiting—and waiting—for approval…
Case Studies
The Regulatory Affairs (RA) group for a major pharmaceutical company was operating as a passive participant in the drug product life cycle. Cross-functional teams were…
Articles
Before They Break You You’ve heard the stereotypes before: large companies are bureaucratic nightmares, care little to none about the details, and have huge sums…